Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
20 Nov, 2025Executive summary
Net sales for the nine months ended 30 September 2025 reached €1,444,363, up from €1,193,264 in the same period last year.
Profit after tax for the period was €95,459, compared to €84,391 year-over-year.
Earnings per share increased to €0.226 from €0.200 year-over-year.
Financial highlights
Operating income before tax was €95,502, up from €84,431 in the prior year period.
Total assets as of 30 September 2025 were €2,370,292, compared to €2,268,344 at year-end 2024.
Shareholders' equity increased to €1,987,062 from €1,891,603 at year-end 2024.
Net cash flow from operating activities was €19,659, up from €5,468 in the prior year period.
Outlook and guidance
Financial information is unaudited and prepared using consistent accounting principles as previous reports.
Latest events from Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija
- Net turnover grew 24.5% year-over-year, but profit before tax fell 6% to €57.7k.SCM1R
Q2 202521 Aug 2025 - Net sales rose 6% but net profit and EPS declined for the nine months of 2024.SCM1R
Q3 202413 Jun 2025 - Net turnover up 1% to €768.3k, but profit before tax down 27.6% to €61.4k.SCM1R
Q2 202413 Jun 2025 - 2024 net profit rose 23.5% to €80.8k, driven by genetics sales growth and stable operations.SCM1R
Q4 20249 Jun 2025 - Net sales up 24% and net profit increased, but operating cash flow turned negative.SCM1R
Q1 20256 Jun 2025